The core function of the Screening Group (SCR) at IARC is to provide data on the accuracy, reproducibility, efficacy, benefits, harmful effects, and cost-effectiveness of various early detection interventions for breast, cervical, colorectal, and oral cancers, among others, in reducing deaths and improving patients’ quality of life in various settings. These data can then be used to inform and improve the rational use of health-care resources. The Group’s ultimate objective is to guide the development of public health policies for implementing screening in a variety of health-care settings, in particular in low- and middle-income countries (LMICs).
SCR conducts field studies in LMICs to evaluate various early detection methods for breast, cervical, colorectal, and oral cancer control. These initiatives also address the means by which screening services could be scaled up through local public health services. SCR develops various training resources to catalyse and augment capacity building in close collaboration with national institutions and government health services. Through its research programme, SCR generates scientific evidence to support the development of resource-appropriate early detection policies and health systems for the delivery of effective early services. The Cancer Screening in 5 Continents (CanScreen5) project of the Group aims to collect information on characteristics and performance of cancer screening programmes around the world and disseminate such information for informed decision making in cancer screening programmes. For example, the Group significantly contributed also to the evaluation of the safety and efficacy of less than three doses of the HPV vaccine in protecting against cervical cancer.
Postdoctoral Fellowships: Mrs Charlotte Bauquier, PhD in social psychology15/07/2019 – 31/12/2019
Charlotte Bauquier, PhD in social psychology, has recently joined the screening group at IARC as a postdoctoral fellow. She will work with Dr Patricia Villain until the end of December at first instance. Charlotte will be involved in implementing an online education intervention regarding HPV vaccination and targeting French general practitioners (PAPRICA project) . She will also conduct a literature review on shared decision aids and evaluation instruments in breast cancer screening used in France in the last 5 years (CANelles project).
Visit of Dr Suleeporn Sangrajrang, National Cancer Institute, Bangkok, Thailand08/07/2019 – 10/07/2019
Dr Suleeporn Sangrajrang, Deputy Director, Health System Development from the National Cancer Institute in Thailand visited the Screening group to work on the Cancer Screening in 5 continents (CanScreen5) project and to discuss areas of potential collaborations.
WHO New essential medicines and diagnostics lists published today09/07/2019
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. Published today, the two lists focus on cancer and other global health challenges, with an emphasis on effective solutions, smart prioritization, and optimal access for patients. WHO added 12 tests to the WHO Essential Diagnostics List to detect a wide range of solid tumours such as colorectal, liver, lymphoma, cervical, prostate, breast and germ cell cancers, as well as leukemia and lymphoma. Visit the WHO updates global guidance on medicines and diagnostic tests to address health challenges, prioritize highly effective therapeutics, and improve affordable access.
|Vale D.B., Filho C.C., Shinzato J.Y., Spreafico F.S., Basu P., Zeferino L.C. Downstaging in opportunistic breast cancer screening in Brazil: a temporal trend analysis. BMC Cancer. 2019 May 10;19(1):432.|
|Mahajan M., Naik N., Jain K., Patira N., Prasad S., Mogri S., Muwonge R., Lucas E., Faruq F., Sankaranarayanan R., Iyer S., Basu P. Study of Knowledge, Attitudes, and Practices Toward Risk Factors and Early Detection of Noncommunicable Diseases Among Rural Women in India. J Glob Oncol. 2019 Apr;(5):1-10.|
|Vale D.B.,Sauvaget C., Murillo R., Muwonge R., Zeferino L.C., Sankaranarayanan R. Correlation of Cervical Cancer Mortality with Fertility, Access to Health Care and Socioeconomic Indicators. Rev Bras Ginecol Obstet. 2019 Mar 25.|